Every nerve that is cut carries a quiet memory of its own repair, and sometimes that repair goes astray. When regrowing fibers fail to find the organ they were reaching for, they knot into a painful tangle called a neuroma, a condition that often follows an unrepaired injury or an amputation. In a study led by Kyle Eberlin, researchers examined ten such tangles removed from patients beside six healthy nerves, and found in the damaged tissue a clear chemical signature of nerves that are still striving to grow and yet are wired to overreact. The finding does not yet heal anyone, but it marks the
Study Maps Molecular Targets Behind Painful Nerve Neuromas, Pointing Toward New Treatments
Patients with neuromas after nerve injury or amputation experience chronic pain and hypersensitivity to touch.
Ten neuromas, six healthy nerves, and a 84% to 3% gap in one pain marker
Mark
So what did this study actually do?
Mimi
It compared ten neuromas removed in surgery with six healthy nerves from lower legs amputated for other reasons, using molecular markers.
Mark
And what stood out?
Mimi
CGRP, a pain-related neuropeptide. It showed up in 84% of axons in the neuromas and just 3% in healthy nerves.
Luke
That's a big gap, but it's ten against six. Small numbers.
Mark
What about the other findings?
Mimi
Higher Piezo2 and Nav1.3, which the authors take as signs of nerves that are excitable and touch-sensitive. The axons were also disorganized, with lots of sympathetic fibers.
Luke
Worth saying that's a description of difference. The study doesn't show these changes cause the pain, or that blocking them relieves it.
Mark
Why mention birds and mammals?
Mimi
Regeneration is ancient, but neuromas appear only in birds and mammals, so they're a more recent development.
Luke
Right, and nothing here says a treatment exists yet. The authors say these are potential targets. Trials would have to test that.
Der Puls
- Regrowing nerve fibers that never reach their target are knotting into painful neuromas in patients who have suffered unrepaired injuries or amputations.
- Ten excised neuromas were set against six healthy nerves, and the contrast was stark: CGRP appeared in 84% of axons in the tangles versus just 3% in healthy tissue.
- Elevated Piezo2 and Nav1.3 channels suggest these nerves are hyperexcitable, firing at the lightest touch and turning ordinary contact into chronic pain.
- The researchers have mapped three molecular candidates for new drugs, but the leap from sample to treatment remains untested and will demand clinical trials on a small evidence base.
Every nerve that is cut carries a quiet memory of its own repair, and sometimes that repair goes astray. When regrowing fibers fail to find the organ they were reaching for, they knot into a painful tangle called a neuroma, a condition that often follows an unrepaired injury or an amputation. In a study led by Kyle Eberlin, researchers examined ten such tangles removed from patients beside six healthy nerves, and found in the damaged tissue a clear chemical signature of nerves that are still striving to grow and yet are wired to overreact. The finding does not yet heal anyone, but it marks the places where future medicine might learn to quiet a nerve that has forgotten how to stop reaching.
Ten neuromas, cut from patients, were laid beside six healthy nerves taken from lower legs amputated for unrelated reasons. Led by Kyle Eberlin, the research team set out to learn why some injured nerves turn into a lasting source of pain.
The puzzle begins with a paradox. Human nerves can regrow after damage, but when the new fibers never reach the organ they were aiming for, they tangle into a neuroma. These commonly form when an injury goes unrepaired or after an amputation. Regeneration itself is ancient, found across animals from nematodes to fish, while neuroma formation appears only later in birds and mammals.
Under the microscope, the neuromas showed disorganized fibers, strong signs of a nerve still trying to grow, and many sympathetic fibers. The sharpest difference lay in CGRP, a pain-related neuropeptide, present in 84% of neuroma axons compared with 3% in healthy nerves. Increased Piezo2 and Nav1.3 channels pointed the same way, suggesting nerves that are highly excitable and sensitive to touch, matching the chronic pain and hypersensitivity patients describe.
The authors see these differences as possible targets for future therapies, though this study only maps where to look. Any drug aimed at CGRP, Piezo2 or Nav1.3 would still need clinical trials, and the small sample is a reminder to proceed carefully.
Ten neuromas, surgically removed from patients, sat at the center of a new study into why some injured nerves end up as a source of lasting pain. Researchers led by Kyle Eberlin set those samples beside six healthy nerves, taken from lower legs that were being amputated for unrelated reasons, and tested both for a panel of molecular markers.
The starting point is a paradox of biology. Human peripheral nerves can regrow after damage. But when the regrowing axons never reach the organ they were headed for, they can form a painful tangle called a neuroma. In humans, these commonly appear when a nerve injury is not repaired surgically, or after an amputation.
The source notes that the ability to regenerate axons is ancient. Animals from nematodes to fish show it. Neuroma formation, by contrast, is a more recent evolutionary development, found in birds and mammals.
When the team looked at the excised neuromas, the axonal components were disorganized in structure. They carried high levels of markers for regenerative capacity, which fits a nerve that is still trying to grow. They also contained an abundance of sympathetic nerve fibers.
The sharpest contrast involved calcitonin gene-related peptide, or CGRP, a neuropeptide involved in pain perception. It was expressed in 84% of axons in the neuromas, compared with 3% in the healthy nerves.
Two other findings pointed the same way. The neuromas showed increased expression of Piezo2, a mechanosensitive channel, and upregulation of Nav1.3, a low-threshold sodium channel. Together, the authors read these as signs that the nerves were highly excitable and sensitive to touch. That matches what patients with neuromas experience after nerve injury or amputation: chronic pain and hypersensitivity.
The authors say any of these differences from healthy nerve tissue could potentially serve as a target for new therapies. The study maps where to look rather than testing a treatment, so any drug aimed at CGRP, Piezo2 or Nav1.3 would still need clinical trials. The sample is small, ten neuromas against six healthy nerves, which is worth keeping in mind as that work begins.
Bemerkenswerte Zitate
Any of these differences from healthy nerves could potentially be targets for novel therapeutic interventions.— The study's authors (paraphrased)
Möchten Sie die ganze Geschichte?
Das Original lesen bei News-Medical.net ↗
Health & Medicine